Kelley W N, Wyngaarden J B
J Clin Invest. 1970 Mar;49(3):602-9. doi: 10.1172/JCI106271.
In the present study we have examined the effects of allopurinol and oxipurinol on the de novo synthesis of purines in cultured human fibroblasts. Allopurinol inhibits de novo purine synthesis in the absence of xanthine oxidase. Inhibition at lower concentrations of the drug requires the presence of hypoxanthine-guanine phosphoribosyltransferase as it does in vivo. Although this suggests that the inhibitory effect of allopurinol at least at the lower concentrations tested is a consequence of its conversion to the ribonucleotide form in human cells, the nucleotide derivative could not be demonstrated. Several possible indirect consequences of such a conversion were also sought. There was no evidence that allopurinol was further utilized in the synthesis of nucleic acids in these cultured human cells and no effect of either allopurinol or oxipurinol on the long-term survival of human cells in vitro could be demonstrated. At higher concentrations, both allopurinol and oxipurinol inhibit the early steps of de novo purine synthesis in the absence of either xanthine oxidase or hypoxanthine-guanine phosphoribosyltransferase. This indicates that at higher drug concentrations, inhibition is occurring by some mechanism other than those previously postulated.
在本研究中,我们检测了别嘌醇和氧嘌呤醇对培养的人成纤维细胞中嘌呤从头合成的影响。在没有黄嘌呤氧化酶的情况下,别嘌醇抑制嘌呤的从头合成。与体内情况一样,在较低药物浓度下的抑制作用需要次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶的存在。尽管这表明别嘌醇至少在所测试的较低浓度下的抑制作用是其在人细胞中转化为核糖核苷酸形式的结果,但未能证实核苷酸衍生物的存在。还探索了这种转化的几种可能的间接后果。没有证据表明别嘌醇在这些培养的人细胞中被进一步用于核酸合成,并且未证明别嘌醇或氧嘌呤醇对人细胞在体外的长期存活有影响。在较高浓度下,在没有黄嘌呤氧化酶或次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶的情况下,别嘌醇和氧嘌呤醇均抑制嘌呤从头合成的早期步骤。这表明在较高药物浓度下,抑制作用是通过先前假设以外的某种机制发生的。